de Boer SA, Reijrink M, Abdulahad WH, Hoekstra ES, et al. Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase-4 inhibitor Linagliptin. A subanalysis from a randomized, placebo controlled trial (RELEASE study). Diabetes Obes Metab 2020 Mar 12. doi: 10.1111/dom.14024.
PMID: 32166899